Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit You

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Journal of the National Cancer Institute|July 5, 2012
Quality of reporting of modern randomized controlled trials in medical oncology: a systematic reviewJulien Péron, Gregory R Pond, Hui K Gan, et al.
International Journal of Cancer|January 18, 2019
A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitorsPatrick Arnaud-Coffin, Denis Maillet, Hui K Gan, et al.
Gynecologic Oncology|April 15, 2014
Dynamic modeling in ovarian cancer: an original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help decisions in early drug developmentMélanie Wilbaux, Emilie Hénin, Amit Oza, et al.
The Prostate|May 29, 2009
Prognostic value of modeled PSA clearance on biochemical relapse free survival after radical prostatectomyBenoit You, Pascal Girard, Philippe Paparel, et al.
Cancers|August 29, 2020
Front-Line Maintenance Therapy in Advanced Ovarian Cancer-Current Advances and PerspectivesThibaut Reverdy, Christophe Sajous, Julien Péron, et al.
Frontiers in Oncology|May 26, 2022
Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in Ovarian Cancer: An Umbrella Review of Meta-AnalysesAmine Souadka, Hajar Essangri, Mohammed Anass Majbar, et al.
Clinical Genitourinary Cancer|January 26, 2016
Identification of Most Aggressive Carcinoma Among Patients Diagnosed With Prostate Cancer Using Mathematical Modeling of Prostate-Specific Antigen IncreasesFélicité de Charry, Olivier Colomban, Benoit You, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Cracking the homologous recombination deficiency code: how to identify responders to PARP inhibitorsLola Paulet, Alexis Trecourt, Alexandra Leary, et al.
American Journal of Obstetrics and Gynecology|October 4, 2015
Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13Pierre-Adrien Bolze, Cécilia Riedl, Jérôme Massardier, et al.
Cancer Treatment Reviews|September 26, 2021
The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomasBenoit You, Gilles Freyer, Antonio Gonzalez-Martin, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Journal of the National Cancer Institute|July 5, 2012
Quality of reporting of modern randomized controlled trials in medical oncology: a systematic reviewJulien Péron, Gregory R Pond, Hui K Gan, et al.
International Journal of Cancer|January 18, 2019
A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitorsPatrick Arnaud-Coffin, Denis Maillet, Hui K Gan, et al.
Gynecologic Oncology|April 15, 2014
Dynamic modeling in ovarian cancer: an original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help decisions in early drug developmentMélanie Wilbaux, Emilie Hénin, Amit Oza, et al.
The Prostate|May 29, 2009
Prognostic value of modeled PSA clearance on biochemical relapse free survival after radical prostatectomyBenoit You, Pascal Girard, Philippe Paparel, et al.
Cancers|August 29, 2020
Front-Line Maintenance Therapy in Advanced Ovarian Cancer-Current Advances and PerspectivesThibaut Reverdy, Christophe Sajous, Julien Péron, et al.
Frontiers in Oncology|May 26, 2022
Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in Ovarian Cancer: An Umbrella Review of Meta-AnalysesAmine Souadka, Hajar Essangri, Mohammed Anass Majbar, et al.
Clinical Genitourinary Cancer|January 26, 2016
Identification of Most Aggressive Carcinoma Among Patients Diagnosed With Prostate Cancer Using Mathematical Modeling of Prostate-Specific Antigen IncreasesFélicité de Charry, Olivier Colomban, Benoit You, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Cracking the homologous recombination deficiency code: how to identify responders to PARP inhibitorsLola Paulet, Alexis Trecourt, Alexandra Leary, et al.
American Journal of Obstetrics and Gynecology|October 4, 2015
Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13Pierre-Adrien Bolze, Cécilia Riedl, Jérôme Massardier, et al.
Cancer Treatment Reviews|September 26, 2021
The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomasBenoit You, Gilles Freyer, Antonio Gonzalez-Martin, et al.
Pageof 15